In summary, our findings demonstrate that miR-455-5p mediates galangin's anti-tumor effect and inhibits CCA cells proliferation, migration, and invasion, at least in part, by targeting PPP1R12A, an effect that decreases MAPK and PI3K/Akt pathway activation in CCA cells. This evidence concerns the gene AKT1 and cholangiocarcinoma.